KCT0008809尚未招募Unknown
Evaluation of tau deposition using Florzolotau in young, healthy volunteers
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20(Year) 至 40(Year)（—）
- 性别
- All
入选标准
- •Healthy subjects aged 20 or older but younger than 40 years old.
排除标准
- •-Pregnant women (Excluded if there is even the slightest suspicion of pregnancy based on questionnaire responses, including the last menstrual date).
- •-Currently breastfeeding women.
- •-Patients with such poor overall health that it is difficult to perform the examination.
- •-Individuals with conditions such as claustrophobia or other seizures.
- •-Patients with clear diagnoses of other causes of dementia or major neurological conditions, including traumatic brain injury, Parkinson's disease, Huntington's disease, motor neuron diseases, multiple sclerosis, etc.
- •-Patients diagnosed with psychiatric disorders such as schizophrenia.
- •-Patients with brain tumors, hydrocephalus, encephalitis, metabolic encephalopathies.
- •-Women who are pregnant or using intrauterine contraceptive devices.
- •-Individuals with cardiac pacemakers or metallic substances implanted inside the body (However, exclusion does not apply if the implanted/transplanted material is titanium or a titanium alloy or if a specialist has confirmed that there are no issues with a 3T MRI scan).
- •-Patients with metallic substances in the brain area, such as brain vascular clips, orthodontic devices, that can cause distortion of the MRI image.
- •-Individuals who have been exposed to radiation exceeding an effective dose of 50msV (5rem) in the past year.
- •-Individuals who have undergone PET scans, coronary angiograms, abdomen-pelvic CT scans, or similar procedures more than twice in the past year.
- •-Individuals working in jobs with significant radiation exposure.
- •-Other individuals who are deemed inappropriate for participation by the clinical investigator.
研究者
相似试验
已完成
不适用
Quantification of tau deposition using positron emission tomography with [11C]PBB3Healthy volunteer and Alzheimer's diseaseJPRN-UMIN000009052ational Institute of Radiological Sciences20
已完成
2 期
Validating in vivo quantification of tau with [18F]AV-1451 PET1001462310012272dementiaAlzheimer's DiseaseNL-OMON47001Vrije Universiteit Medisch Centrum15
进行中（未招募）
1 期
Measuring the amount of tau bindingAlzheimer's Disease (AD)MedDRA version: 18.1 Level: PT Classification code 10012271 Term: Dementia Alzheimer's type System Organ Class: 10029205 - Nervous system disordersMedDRA version: 18.1 Level: HLT Classification code 10001897 Term: Alzheimer's disease (incl subtypes) System Organ Class: 10029205 - Nervous system disordersMedDRA version: 18.1 Level: LLT Classification code 10001896 Term: Alzheimer's disease System Organ Class: 10029205 - Nervous system disordersEUCTR2015-004230-10-NLVU University Medical Center15
招募中
不适用
Mapping of brain tau deposition in tauopathy by PET with [18F]PM-PBB3mild cognitive impairment, Alzheimer's disease, corticobasal degeneration, progressive supranuclear palsy, frontotemporal degeneration, Parkinson's disease, Lewy body dementia,Amyotrophic Lateral Sclerosis/Parkinsonism-Dementia Complex Patients in Kii Peninsula, Diffuse neurofibrillary tangles with calcification, hereditary diffuse leukoencephalopathy with spheroid,Progressive Ataxia and Palatal Tremor, traumatic brain injuryJPRN-UMIN000030248ational Institute of Radiological Sciences200
已完成
不适用
Quantitative analysis of effect of topical tafluprost on ocular blood flow in normal subjectsnormal subjectsJPRN-UMIN000004818Department of Ophthalmology,University of Tokyo Graduate School of Medicine12